The UILO is actively engaged in the creation and development of UBC spin-off companies, based on UBC research discoveries.
As at March 31, 2019, UBC research has been instrumental in creating 213 spin-off companies. Approximately 130 of those companies are understood to be currently active, or to have merged or been acquired.
UBC's most commercially successful spin-off company to date. QLT developed the research led by Drs. Julia Levy and David Dolphin to create Visudyne, a light-activated drug to treat age-related wet macular degeneration - a leading cause of vision loss.
Founded around Dr. Phil Hill's discovery of a technology that enables diesel engines to run on clean-burning natural gas. Westport is now a leading employer in BC and sells advanced natural gas and propane engines, fuel systems and components to customers in more than 70 countries.
Commercializes biomarker blood tests developed by Dr. Aziz Ghahary at Vancouver General Hospital for the personalized treatment of rheumatoid arthritis.
Provides fully automated, enterprise-grade integration of software development tools. Founded on technology developed by Drs. Gail Murphy and Mik Kersten. Based in Vancouver with offices in the USA and UK.
Based on a novel reactor design developed by Dr. Don Mavinic at UBC, Ostara designs, builds and markets a proprietary nutrient recovery technology that transforms phosphorus and nitrogen recovered from municipal and industrial wastewater into a high-value, eco-friendly fertilizer, sold and marketed as Crystal Green®
Developing highly efficient, low maintenance and low power ultraviolet light emitting diode (UV-LED) water purification systems for processing low to moderate volumes of water for drinking water applications for mobile and off grid situations.
A clinical-stage biomedical company focused on the clinical evaluation, development and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation.
Paragon Testing Enterprises
Canada’s leader in English language proficiency tests for those wishing to immigrate to Canada, to become Canadian citizens, or to study in Canada at all levels.
Commercializes proprietary platforms and companion reagent kits to enable the simplified manufacture of novel nanoparticles used in medicine and medical research. The technology was developed through a collaboration between Drs. Carl Hansen and Pieter Cullis at UBC.Read More